France vs Oman: Treatment success rate for patients treated for MDR-TB
France
3.0%
in 2022
Oman
0.0%
in 2022
France rank
158th
Oman rank
159th
Treatment success rate for patients treated for MDR-TB over time
- France
- Oman
How they compare
France currently reports 3.0% against 0.0% in Oman, a difference of 3.0%.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Oman ahead.
France ranks 158th and Oman ranks 159th of 163 countries.
Across the 2 decades both report, France averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | France | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.0% | 12.5% | 6.5% | Oman |
| 2020s | 1.7% | 0.0% | 1.7% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, France or Oman?
- France, at 3.0% against 0.0% in Oman as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between France and Oman?
- 3.0%, with France ahead.
- How many years of comparable data are there for France and Oman?
- 5 years are reported by both, from 2018 to 2022.
- How do France and Oman rank globally for treatment success rate for patients treated for mdr-tb?
- France ranks 158th and Oman ranks 159th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.